Clinical trial cost calculator

Clinical trial cost calculator

Understand your clinical trial costs

Are your clinical trials risky? Are costs running away?

It’s very tricky to estimate clinical trial costs before a trial is run.

Try our free clinical trial cost calculator. This is a regression model for clinical trial cost breakdowns, trained on real clinical trial data.

Trial is for condition
Phase
Vaccine trial?
Country
Sample size
Number of interventions
Click button to estimate cost in dollars

Do you want to calculate clinical trial cost directly from the protocol?

A large amount of the data needed to estimate the total cost of a clinical trial is contained within the unstructured text of the protocol. Notably, some items, such as CRO costs, will need to be inferred (examples include the number of CRA meetings, and the expected number of adverse events and serious adverse events).

The Clinical Trial Risk Tool, developed by Fast Data Science, will let you upload a PDF protocol and will directly identify some risk and cost features. We have a top-down approach to cost modelling where we have trained a model on past trials and predict the cost of a planned trial based on key features such as sample size, but we are currently developing a bottom-up approach which would allow the generation of an itemised budget in spreadsheet form.

How did we train this cost calculator?

Unlike other clinical trial cost calculators you may find online, our clinical trial cost models are regression models trained on past trials. You can download the training dataset here - the original source is here.

Here’s a preview of our training data that we used to develop our regression models:

IndicationTechnologyNCT#Tech IIEnrollmentTrial PhaseTotal CostPer Patient Cost ($PP)Source for this DataName of the Source
Advanced Myeloid Malignancybiologic drug-30Phase 1$328,000.00$10,933docSEC agreements
Blood Cancerbiologic drugNCT034833249Phase 1$5,000,000.00$555,556docCIRM
Blood Cancerbiologic drugNCT0392593524Phase 1$6,192,579.00$258,024docCIRM
B cell cancers, Leukemiabiologic drugNCT03088878156Phase 1/2$18,292,674.00$117,261docCIRM
Blood Cancerbiologic drugNCT0222268826Phase 1$4,179,598.00$160,754docCIRM
Colon Cancerbiologic drugNCT02953782112Phase 1/2$10,234,048.00$91,375docCIRM
Leukemia, Acute Myeloid (AML)biologic drugNCT0324847996Phase 1$5,000,000.00$52,083docCIRM
Blood Cancer, Solid Tumorsbiologic drugNCT0221640988Phase 1$6,505,568.00$73,927docCIRM
Breast Cancerbiologic drugNCT00781612720Phase 3-$104,186.49https://docKEI FOIA Response/University of Colorad
Stage IV Melanomacell therapyNCT0043898411Phase 1$936,164.00$85,106docFOIA’d NIH grants

Why use natural language processing for clinical trial cost calculations?

The Clinical Trial Risk Tool:

  • Saves time reading lengthy clinical trial documents
  • Identifies any factors that could indicate your trial is risky
    • Boehringer Ingelheim improved their financial modelling using AI tools developed by Fast Data Science
    • The Bill and Melinda Gates Foundation is using our tool to triage HIV and TB trials into high and low risk
    • A quarter of trials fail. The Gates Foundation is able to identify high risk trials using our tool and avoid funding risky trials.
  • Creates a report detailing the analysis of your trial
  • Estimates a cost in dollars of running your trial, based on machine learning models trained on real data in your field. If you disagree with the cost weightings used in the tool, you can easily adjust them for your field. For example, if you are working in a field where trial costs tend to be very high, such as cell therapy or gene therapy, you may want to adjust the tool’s average cost per subject. If this is the case, please contact us to discuss your needs.
  • Provides transparent and understandable cost and risk estimates for all trial phases
  • Does not send your data to any third party AI companies, and does not rely on generative AI
  • Based on published peer-reviewed research

We originally developed the Clinical Trial Risk Tool to estimate costs of Tuberculosis and HIV trials. In 2024, we extended the scope of our clinical trial cost software to cover other disease indications including:

In addition to cost estimation, the Clinical Trial Risk Tool also provides clinical trial risk assessment (how to quantify the risk of a trial ending without delivering informative results), and clinical trial complexity.

Pain points running a clinical trial

  • When you’re planning a clinical trial, you have to write the protocol.

  • This is a PDF document which is 200 pages long.

  • It says what drug you are testing, who will participate in your trial, over what time period, and what they will be required to do. It may also say how you will manufacture the drug, how it will be delivered, where the trial will take place, and how you will analyse the data.

  • If you want an organisation to fund your trial (a sponsor), they will need to read the protocol and estimate the cost, and be satisfied that the trial is not too risky.

  • To complete this risk assessment and cost assessment, you will need experts in multiple fields to read and assess the protocol. This is subjective (different people might come to different conclusions) and it’s slow.

Find out about trial costs

Talk to us about trial costs

Talk to us about your clinical trial and how we can help you calculate clinical trial costs. If your trial is in a disease area which we have not covered, or you think we should be looking for something in the protocol which we don’t already extract, we can discuss adding features to the Clinical Trial Risk Tool.

Fast Data Science’s value proposition for the Clinical Trial Risk Tool

The Clinical Trial Risk Tool unifies the technical knowledge in the protocol (medical or statistical information) with the business knowledge (finances, risk management) for clinical trial cost analysis.

Imagine you could have a tool which could read your protocols and estimate the cost and risk, immediately!

If you work for the trial sponsor, this works along with other clinical trial budget software to triage the protocols that you receive from investigators, identifying who’s worth pursuing.

In a pharmaceutical company, this helps your business plan cash flow and quantify and diversify risk.

If you are investing in pharmaceutical development, this helps you understand your exposure to risk.

If you’re a CRO (contract research organisation, i.e. the company that is contracted to run the trials), you can prepare quotes and cost estimates for your clients (pharma companies) quickly and easily.

See also

Clinical trial regulations in 2025: navigating the constraints

Clinical trial regulations in 2025: navigating the constraints

Guest post by Safeer Khan, Lecturer at Department of Pharmaceutical Sciences, Government College University, Lahore, Pakistan Introduction As we move toward 2025, clinical trial regulations are undergoing significant transformation. This shift is being fueled by technological advancements, changing healthcare needs, and an increasing emphasis on transparency and patient safety. In this post, we will explore the key clinical trial regulations shaping the clinical trial landscape, the challenges professionals face, and the strategies they must adopt to navigate this ever-evolving environment.

Clinical Trial Files podcast episode

Clinical Trial Files podcast episode

Thomas Wood has recently joined the Clinical Trial Files podcast with Karin Avila and Taymeyah Al-Toubah, discussing the inception of the Clinical Trial Risk Tool, what impact AI can make in clinical trials, and what Alan Turing would make of it all. This is an episode dedicated to Alan Turing’s 113th birthday on 23 June 2025. You can find the episode on Spotify Apple Podcasts Amazon Music Podcast Index Fountain Podcast Addict Podverse.

Understanding clinical trial feasibility and the cost component

Understanding clinical trial feasibility and the cost component

Guest post by Youssef Soliman, medical student at Assiut University and biostatistician Before launching a clinical study, even the most promising idea must be vetted for feasibility. In other words, can this trial be executed successfully in the real world? Feasibility assessments examine practical factors like available patients, site capabilities, timelines, and budget. This step is crucial. A majority of trials encounter delays or enrollment shortfalls (by some estimates, 70–80% of trials) [1], driving up costs and risking failure.